- Home
- INO vs ACR Comparison
INO vs ACR Comparison
Compare INO & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- ACR
- Stock Information
- Founded
- INO 1979
- ACR 2005
- Country
- INO United States
- ACR United States
- Employees
- INO N/A
- ACR N/A
- Industry
- INO Medical/Dental Instruments
- ACR Real Estate Investment Trusts
- Sector
- INO Health Care
- ACR Real Estate
- Exchange
- INO Nasdaq
- ACR Nasdaq
- Market Cap
- INO 136.6M
- ACR 143.3M
- IPO Year
- INO 1998
- ACR N/A
- Fundamental
- Price
- INO $1.77
- ACR $20.42
- Analyst Decision
- INO Buy
- ACR Buy
- Analyst Count
- INO 5
- ACR 2
- Target Price
- INO $9.00
- ACR $24.50
- AVG Volume (30 Days)
- INO 1.4M
- ACR 21.8K
- Earning Date
- INO 11-10-2025
- ACR 10-29-2025
- Dividend Yield
- INO N/A
- ACR N/A
- EPS Growth
- INO N/A
- ACR 14.65
- EPS
- INO N/A
- ACR 0.95
- Revenue
- INO $182,337.00
- ACR $88,952,000.00
- Revenue This Year
- INO N/A
- ACR $7.03
- Revenue Next Year
- INO $14,751.49
- ACR $3.26
- P/E Ratio
- INO N/A
- ACR $21.92
- Revenue Growth
- INO N/A
- ACR 14.87
- 52 Week Low
- INO $1.30
- ACR $14.94
- 52 Week High
- INO $4.61
- ACR $23.81
- Technical
- Relative Strength Index (RSI)
- INO 31.56
- ACR 38.86
- Support Level
- INO $1.93
- ACR $21.31
- Resistance Level
- INO $2.11
- ACR $21.61
- Average True Range (ATR)
- INO 0.14
- ACR 0.47
- MACD
- INO -0.05
- ACR -0.10
- Stochastic Oscillator
- INO 0.43
- ACR 21.22
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.